After decades of modest advances, psoriasis research has caught fire. The drug pipeline is full of novel agents. Research into the role of the immune system in this skin disease is bearing fruit. Genetic studies hint at the condition's starting point. And now psoriasis is a proof-of-principle disease for other chronic inflammatory conditions.
